GJB1 and neurodegenerative disease: Therefore, we hypothesize that Cx32 upregulation may first occur during the early stages of the disease as shown for other Cx in different neurodegenerative diseases [49], followed by a downregulation in late stages as a protective mechanism to reduce the uptake and accumulation of α-syn pathology; however, additional studies are needed to validate this hypothesis.